Preview

Нервно-мышечные болезни

Расширенный поиск

Основные разновидности воспалительных миопатий: морфологическая дифференциальная диагностика


https://doi.org/10.17650/2222-8721-2012-0-1-7-10

Полный текст:

Аннотация

В обзоре представлены морфологические подходы диагностики основных нозологических форм воспалительных миопатий. Отражены принципы взятия биоптатов скелетных мышц и методы их гистологической обработки. Дана характеристика гистохимических и иммуногистохимических тканевых маркеров этих заболеваний. Представлены некоторые спорные вопросы морфологической диагностики, а также возможные диагностические ошибки.

Об авторе

С. Г. Раденска-Лоповок
ФГБУ НИИ ревматологии РАМН, Москва
Россия


Список литературы

1. Dalakas M.C. Polymyositis, dermatomyositis, and inclusion-body myositis. N Engl J Med 1991;325:1487−98.

2. Dalakas M.C., Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003; 362:971−82.

3. Dalakas M.C., Karpati G. The inflammatory myopathies. In: Disorders of Voluntary Muscle 8th edn. Eds G. Karpati, D. Hilton-Jones, K. Bushby, R.C. Griggs. Cambridge: Cambridge University Press, 2010;427−52.

4. Dalakas M.C. Polymyositis, dermatomyositis and inclusion body myositis. Harrison’s Principles of Internal Medicine 17th edn. Eds A.S. Fauci, E. Braunwald, D.L. Kasper, S.L. Hauser, D.L. Longo, J.L. Jameson, J. Loscalzo. New York, NY: McGraw-Hill, 2008; 2696−703.

5. Mastaglia F.L., Phillips B.A. Idiopathic inflammatory myopathies: epidemiology, classification and diagnostic criteria. Rheum Dis Clin North Am 2002;28:723−41.

6. Dalakas M.C. Inflammatory muscle diseases: a critical review on pathogenesis and therapies. Curr Opin Pharmacol 2010;10:346−52.

7. Schmidt J., Dalakas M.C. Pathomechanisms of inflammatory myopathies: recent advances and implications for diagnosis and therapies. Expert Opin Med Diagn 2010;4:241−50.

8. Dalakas M.C. Sporadic inclusion body myositis — diagnosis, pathogenesis and therapeutic strategies. Nat Clin Pract Neurol 2006;2:437−47.

9. Lunberg I., Ulfgren A.-K., Nyberg P. et al. Cynokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum 1997; 40:865−74.

10. Needham M., Fabian V., Knezevic W. et al. Progressive myopathy with upregulation of MHC-I associated with statin therapy. Neuromuscul Disord 2007;17:194−200.

11. Askanas V., Engel W.K., Alvarez R.B., Glenner G.G. b-Amyloid protein immunoreactivity in muscle of patients with inclusion-body myositis. Lancet 1992;339:560−1.

12. Askanas V., Engel W.K., Nogalska A. Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation. Brain Pathol 2009;19:493−506.

13. Nogalska A., Terracciano C., D’Agostino C. et al. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis. Acta Neuropathol 2009;118:407−13.

14. Askanas V., Engel W.K., Alvarez R.B. Enhanced detection of Congo-red-positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer disease using fluorescence technique. Neurology 1993;43:1265−7.

15. Karpati G., Carpenter S. Pathology of the inflammatory myopathies. Baillieres Clin Neurol 1993;2:527−56.

16. Griggs R.C., Askanas V., DiMauro S. et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705−13.

17. De Bleecker J.L., Ertl B.B., Engel A.G. Patterns of abnormal protein expression in target formations and unstructured cores. Neuromuscul Disord 1996;6:339−49.

18. Fidzianska A., Rowinska-Marcinska K., Hausmanowa-Petrusewicz I. Coexistence of X-linked recessive Emery-Dreifuss muscular dystrophy with inclusion body myositis-like morphology. Acta Neuropathol 2004;104:197−203.

19. Selcen D., Ohno K., Engel A.G. Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients. Brain 2004;127:439−51.

20. Ferrer I., Martin B., Castano J.G. et al. Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis. J Neuropathol Exp Neurol 2004;63:484−98.

21. Ferrer I., Carmona M., Blanco R. Involvement of clusterin and the aggresome in abnormal protein deposits in myofibrillar myopathies and Inclusion Body Myositis. Brain Pathol 2005;15:101−8.

22. Semino-Mora C., Dalakas M.C. Rimmed vacuoles with b-amyloid and ubiquitinated filamentous deposits in the muscles of patients with long-standing denervation [post-poliomyelitis muscular atrophy]: similarities with inclusion body myositis. Hum Pathol 1998;29:1128−33.

23. Weihl C.C., Temiz., Miller S.E. et al. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry 2008;79:1186−9.

24. Salajegheh M., Pinkus J.L., Nazareno R. et al. Nature of ‘Tau’ immunoreactivity in normal myonuclei and inclusion body myositis. Muscle Nerve 2009;40:520−8.

25. Chahin N., Engel A.G. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Neurology 2008;70:418−24.

26. Karpati G., Pouliot Y., Carpenter S. Expression of immunoreactive major histocompatability complex products in human skeletal muscles. Ann Neurol 1988; 23:64−72.

27. Emslie−Smith A.M., Arahata K., Engel A.G. Major histocompatibility complex class I antigen expression,

28. immunologicalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol 1989; 20:224−31.

29. Dalakas M.C. Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies. Nat Clin Pract Rheumatol 2006;2:219−27.

30. Dalakas M.C. Review: An update on inflammatory and autoimmune myopathy. Neuropathol Appl Neurobiol 2011;37:226−42.


Для цитирования:


Раденска-Лоповок С.Г. Основные разновидности воспалительных миопатий: морфологическая дифференциальная диагностика. Нервно-мышечные болезни. 2012;(1):7-10. https://doi.org/10.17650/2222-8721-2012-0-1-7-10

For citation:


Radenska-Lopovok S.G. Morphological differential diagnosis of the main types of inflammatory myopathies. Neuromuscular Diseases. 2012;(1):7-10. (In Russ.) https://doi.org/10.17650/2222-8721-2012-0-1-7-10

Просмотров: 294


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2222-8721 (Print)
ISSN 2413-0443 (Online)